Overexpression of uridine diphospho glucuronosyltransferase 2B17 in high-risk chronic lymphocytic leukemia.

Blood 2013 Feb 20;121(7):1175-83. Epub 2012 Nov 20.

Department of Internal Medicine I, Division of Hematology and Hemostaseology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.

Uridine diphospho glucuronosyltransferase 2B17 (UGT2B17) glucuronidates androgens and xenobiotics including certain drugs. The UGT2B17 gene shows a remarkable copy number variation (CNV), which predisposes for solid tumors and influences drug response. Here, we identify a yet undescribed UGT2B17 mRNA overexpression in poor-risk chronic lymphocytic leukemia (CLL). In total, 320 CLL patients and 449 healthy donors were analyzed. High (above median) UGT2B17 expression was associated with established CLL poor prognostic factors and resulted in shorter treatment-free and overall survival (hazard ratio ([death] 2.18; 95% CI 1.18-4.01; P = .013). The prognostic impact of mRNA expression was more significant than that of UGT2B17 CNV. UGT2B17 mRNA levels in primary CLL samples directly correlated with functional glucuronidation activity toward androgens and the anticancer drug vorinostat (R > 0.9, P < .001). After treatment with fludarabine containing regimens UGT2B17 was up-regulated particularly in poor responders (P = .030). We observed an exclusive involvement of the 2B17 isoform within the UGT protein family. Gene expression profiling of a stable UGT2B17 knockdown in the CLL cell line MEC-1 demonstrated a significant involvement in key cellular processes. These findings establish a relevant role of UGT2B17 in CLL with functional consequences and potential therapeutic implications.

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2012-08-447359DOI Listing
February 2013
96 Reads

Publication Analysis

Top Keywords

ugt2b17
9
lymphocytic leukemia
8
ugt2b17 mrna
8
diphospho glucuronosyltransferase
8
chronic lymphocytic
8
glucuronosyltransferase 2b17
8
uridine diphospho
8
cll
6
primary cll
4
cll samples
4
expression ugt2b17
4
levels primary
4
ugt2b17 cnv
4
mrna levels
4
cnv ugt2b17
4
directly correlated
4
androgens anticancer
4
anticancer drug
4
drug vorinostat
4
vorinostat 001
4

Similar Publications